• OPEN AN ACCOUNT
Indian Indices
Sensex
76,152.86 -417.49
( -0.55%)
Global Indices
Nasdaq
53,682.77 599.82
(1.13%)
Dow Jones
7,765.55 77.95
(1.01%)
Hang Seng
64,337.38 11.74
(0.02%)
Nikkei 225
10,831.87 75.42
(0.70%)
Forex
USD-INR
94.95 -0.29
(-0.30%)
EUR-INR
110.11 -0.38
(-0.35%)
GBP-INR
128.48 -0.52
(-0.40%)
JPY-INR
0.59 0.00
(-0.47%)

EQUITY - MARKET SCREENER

SEPC Ltd
Industry :  Engineering - Turnkey Services
BSE Code
ISIN Demat
Book Value()
532945
INE964H01014
9.6717525
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SEPC
0
1030.28
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Jenburkt Pharmaceuticals standalone net profit rises 27.05% in the March 2026 quarter
May 06,2026
Net profit of Jenburkt Pharmaceuticals rose 27.05% to Rs 10.85 crore in the quarter ended March 2026 as against Rs 8.54 crore during the previous quarter ended March 2025. Sales rose 8.72% to Rs 44.63 crore in the quarter ended March 2026 as against Rs 41.05 crore during the previous quarter ended March 2025.

For the full year,net profit rose 8.36% to Rs 34.74 crore in the year ended March 2026 as against Rs 32.06 crore during the previous year ended March 2025. Sales rose 11.24% to Rs 168.74 crore in the year ended March 2026 as against Rs 151.69 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales44.6341.05 9 168.74151.69 11
OPM %31.9326.46 -25.9226.63 -
PBDT18.4712.63 46 53.5846.66 15
PBT17.6611.84 49 50.4743.93 15
NP10.858.54 27 34.7432.06 8